Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MIMEDX GROUP, INC.MDXG · Entity 5271 | President, WC & Surgical | August 09, 2022 | August 11, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MIMEDX GROUP, INC.
Report date August 09, 2022 · Filed August 11, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 430,072 |
Reported balance
After 2022-08-09 transaction · row 1
1 source rowRow 1 · 2022-08-09 · Sale · Disposed 12,343 · Balance 430,072 F1: Reflects sale of shares to cover tax withholding obligation upon vesting of previously-granted award. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects sale of shares to cover tax withholding obligation upon vesting of previously-granted award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2022 Filed Aug 11, 2022 18:30 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 12,343 | $4.21 | $51,939.34 |
DisclosureSEC source: 0001376339-22-000108 · wf-form4_166025703691365.xml · nonDerivative · entry 1 Kashyap Rohit · CIK 0001435655 · President, WC & Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,072 F1 · kind: Reflects sale of shares to cover tax withholding obligation upon vesting of previously-granted award. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 17:26 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 178,571 | $4.62 | $824,998.02 |
DisclosureSEC source: 0001376339-22-000040 · wf-form4_164979878492176.xml · nonDerivative · entry 1 Kashyap Rohit · CIK 0001435655 · President, WC & Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,415 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 16:28 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 8,770 | $4.86 | $42,613.43 |
DisclosureSEC source: 0001376339-22-000025 · wf-form4_164694771945794.xml · nonDerivative · entry 1 Kashyap Rohit · CIK 0001435655 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,844 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 16:21 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 99,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001435655-21-000002 · wf-form4_161523845494404.xml · nonDerivative · entry 1 Kashyap Rohit · CIK 0001435655 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,614 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 16:24 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 173,310 | $5.77 | $999,998.70 |
DisclosureSEC source: 0001435655-20-000002 · wf-form4_159657261965046.xml · nonDerivative · entry 1 Kashyap Rohit · CIK 0001435655 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,310 F1 · kind: Represents grant of restricted stock which vests one-third each anniversary. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.